Euro Surveillance 2014;19(47):pii=20970, p.31-37
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information... on their impact and how these issues can be addressed by regulation and control of the supply chain using technology appropriate to the developing world.
more
PLoS Negl Trop Dis 10(7): e0004794. doi:10.1371/journal.pntd.0004794
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
15. Euro Surveill. 2017;22(47):pii=17-00103
New England Journal of Medicine 374:1,pp23-32
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
PLOS ONE | https://doi.org/10.1371/journal.pone.0210937
February 5, 2019
Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute... attacks and management of lymphedema are necessary for the management of the advanced stages of LF. However, very few countries including Zambia, have adequate information on the health beliefs and health seeking behavior of communities living in endemic areas towards MMDP services for LF. This study sought to explore community and health provider perspectives towards MMDP services for LF in a highly endemic region, Luangwa District, Zambia, between February and April 2019.
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0186835 October 30, 2017
PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...t
regimen [1]. The number of these patients is not negligible.
In 2014, of the 6.3 million TB cases that were notified
by National TB Programmes (NTPs) to the World Health
Organization (WHO), approximately 700,000 patients were
already previously treated
more
Public health Panoram, Vol.2 Issue 1 March 2016
Front. Psychiatry, 29 November 2018 | https://doi.org/10.3389/fpsyt.2018.00635